What is the current stock price of Better Therapeutics, Inc. (BTTX)?

As of the latest market data, Better Therapeutics, Inc. (BTTX) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Better Therapeutics, Inc. (BTTX) pay a dividend?

Based on current data, Better Therapeutics, Inc. does not have a confirmed active dividend policy.

What is the market cap of Better Therapeutics, Inc.?

The current market capitalization of Better Therapeutics, Inc. (BTTX) is approximately unavailable.

BTTX

Better Therapeutics, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-03-17

Beta

1.69

Websitewww.bettertx.com↗